Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: David Lenigas answers investor questions in a detailed interview about UKOG, Doriemus, LGC Capital, AfriAg and Angus Energy.


ShareCast News - AIM Bulletin





Physiomics losses widen as major contract awaited

(ShareCast News) - Biology services group Physiomics saw its annual losses widen throughout the year ended 30 June as second-half revenue came in below expectations.
[16 Oct '17 09:58]

Koovs announces collection for N Brown's Simply Be

(ShareCast News) - AIM-listed Koovs has announced a new partnership with online retail group N Brown to add its Koovs Private Label young fashion brand to the company's Simply Be offer.
[16 Oct '17 09:43]

Salt Lake Potash successfully completes unlined pond trial

(ShareCast News) - Salt Lake Potash confirmed the successful completion of field trials testing an on-lake, unlined evaporation pond model on Monday, which it said would result in "significant" capital expenditure savings for the Goldfields Salt Lakes Project (GSLP).
[16 Oct '17 09:42]

Draper Esprit targets 75m-worth of investment in seed funds across Europe

(ShareCast News) - Venture Capital firm Draper Esprit announced on Monday a strategy targeting up to 75m worth of investment in top seed funds across Europe over the next five years, less than a week after its funds had committed 17m into three new Europe-based digital technology businesses.
[16 Oct '17 09:41]

System1 warns investors of 'slower than expected' trading

(ShareCast News) - Marketing and brand consultancy firm System1 warned investors of "slower than expected" first half trading on Monday.
[16 Oct '17 09:04]

Thalassa Holdings confirms sale of shares in Papua Mining

(ShareCast News) - The board of Thalassa Holdings confirmed it had sold 40m ordinary shares in copper and gold exploration company Papua Mining on Monday.
[16 Oct '17 08:48]

Realm Therapeutics CEO to present at 2017 Bio Investor Forum

(ShareCast News) - Biopharma group Realm Therapeutics's chief executive officer will present an update on the firm's two lead drug development programmes at the 2017 BIO Investor Forum in California.
[16 Oct '17 08:35]

Starvest announces Cora Gold as new investee company

(ShareCast News) - AIM-quoted investment company Starvest said it had participated in the recent IPO of Cora Gold, placing both companies in the best position to benefit from increasing interest in precious metals amid an upturn in the gold sector.
[16 Oct '17 08:07]

Bioventix profits shoot higher on vit-D tests, but may plateau

(ShareCast News) - Biotech group Bioventix lifted annual pre-tax profits by more than a third as revenue was boosted by a significant increase in sales of its vitamin D antibody.
[16 Oct '17 08:02]

Amati outperforms net asset value benchmark despite widening discount

(ShareCast News) - London-based venture capital trust Amati's net asset value (NAV) rose significantly through its first half of trading despite its NAV discount widening.
[13 Oct '17 15:39]



Categories: AIM Bulletin, Broker Recommendations, Commodities, Company News, Dealings and Holdings, Economic News, Foreign Exchange, International News, Market Report, New Issues, News and Announcements, Press Round-Up, Risers and Fallers, Small Cap News, Technical Analysis, Tips Round-Up, Week Ahead.


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.